The veteran impact investor is targeting a $81.2m final close to back businesses in West Africa and Madagascar that are too big for microfinance but too small for traditional private equity.
The University of Stellenbosch spinoff is building a new facility in Cape Town to tackle Africa's reliance on imported active pharmaceutical ingredients.
